DLBCL-RT | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

1,762 results for “DLBCL-RT”

Trials

View all 1362 →

R-CHOP14 or R-CHOP21 &Consolidation PET-Oriented Radiotherapy (RT) in DLBCL Patients

109 participants · First posted Dec 6, 2017

Argatroban Plus r-tPA for Posterior Circulation Infarction（AR-PCI）

3 participants · First posted Apr 23, 2018

Pelvic RT Versus Prophylactic Extended-field RT in Patients With Cervical Cancer

638 participants · First posted May 20, 2019

Drugs

View all 78 →

RT-301

RT-201

RT-302

Organizations

Raziel Therapeutics (RT) Ltd

Israel

News

View all 321 →

Atezolizumab, Venetoclax, and Obinutuzumab Show Promise in Richter Transformation DLBCL

Nivolumab Plus Radiotherapy Improves Outcomes in High-Risk Prostate Cancer

Hypofractionated Radiotherapy Non-Inferior to Standard After Mastectomy in Breast Cancer

Page 1 of 177